Wearable insulin pump developer EOflow to go public

[THE INVESTOR] Korea’s biotech firm EOflow confirmed that it will float its shares on the tech-heavy KOSDAQ as it gains confidence with its wearable insulin delivery patch device backed by venture capitalists. The company has hired NH Investment & Securities as lead manager and will apply for preliminary IPO review in May, the company CEO Jesse Kim told The Investor.

The company hopes to get listed by end-2018 when its flagship product EOPatch will begin generating revenue.

Leave a Reply

Your email address will not be published. Required fields are marked *